Akebia Therapeutics granted stock options to new employees, vesting over four years.

From Yahoo Finance: 2025-06-29 03:03:00

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is one of the 10 best healthcare penny stocks to buy according to analysts. The company granted options to purchase an aggregate of 137,000 shares of its common stock to three newly hired employees on May 30, 2025. The exercise price for the options is $3.03 per share, and they vest over a four-year period. Akebia focuses on developing treatments for kidney-related diseases, selling products like Auryxia and Vafseo. While AKBA has potential as an investment, other AI stocks may offer greater upside potential. No promotional content included.



Read more at Yahoo Finance: Akebia Therapeutics (AKBA) Grants Stock Options to New Employees